Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

• Conditions: Coronary Thrombosis

• Registration Number: NCT02591264
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

The aim of this study is to determine the role of human neutrophil peptide-1 to 3 in the occurrence of periprocedural myocardial infarction.

Detailed Description

Not available

Study Timeline

• Status Verified: 2015-10
• Study First Submitted: 2015-10-28
• Study First Submitted QC: 2015-10-28
• Last Update Submitted: 2015-10-28
• Study First Posted: 2015-10-29
• Last Update Posted: 2015-10-29
• Study Start: 2015-11
• Primary Completion: 2016-11
• Study Completion: 2016-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Troponin negative patients
• Stable angina
• Unstable angina
• Positive screening tests

Exclusion Criteria

• Troponin positive
• Technical failure of procedure
• Hemodynamic unstability

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Human Neutrophil Peptide Level	Two hours	Laboratory analysis and measurement of Human Neutrophil Peptide-1 to 3 levels

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel